178 filings
Page 5 of 9
8-K
l6wislx2axjt0jdp5v1f
28 Oct 19
Termination of a Material Definitive Agreement
5:15pm
8-K
ifxy1ohs ik
27 Sep 19
Other Events
5:01pm
8-K
x90iestpk6yse4wpd5
7 Aug 19
Intercept Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
7:15am
8-K
888qswigeqe2dqrxx65
25 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
xbwus5uu2d nouomtuu
14 May 19
Entry into a Material Definitive Agreement
5:09pm
8-K
zgl86c4qbh 1hgaegpth
8 May 19
Intercept Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
7:21am
8-K
5tfvxxw0pjnyul
17 Apr 19
Intercept Reports Additional Positive Data from REGENERATE, the First Successful Phase 3 Study in NASH
5:01pm
8-K
6k5t66w94fyu b6c8tb0
28 Feb 19
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results, Issues 2019 Financial Guidance and Provides Business Update
7:32am
8-K
ldpotl34frxjnoo7
25 Feb 19
Intercept Announces Positive Topline Results from Pivotal Phase 3 REGENERATE Study of Obeticholic Acid in Patients with Liver Fibrosis Due to NASH
5:00pm
8-K
g1rswco9m4kg exrwm
10 Jan 19
Intercept Announces NASH and PBC Program Updates
5:01pm
8-K
j8o4cnecna5p0on izgg
31 Oct 18
Intercept Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
7:32am
8-K
gkjetdinrm8 a6
2 Aug 18
Intercept Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
7:28am
8-K
ozo v8pl9
25 Jun 18
Entry into a Material Definitive Agreement
5:00pm
8-K
1zuxe
8 May 18
Intercept Pharmaceuticals Announces First Quarter 2018 Financial Results, Issues 2018
7:30am
8-K
3ln8swetc kste6x3op
27 Apr 18
Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Board of Directors
8:30am
8-K
9y7xh3pawci17u0tsct
10 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
yo74b15mp ylo
4 Apr 18
Other Events
12:00am
8-K
cl3sadb5za7
26 Mar 18
Other Events
12:00am
8-K
kk8bplyjdj 15xhw0
16 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
h8br f2f2dvl66q
14 Feb 18
Intercept Pharmaceuticals Reports Full Year and Fourth Quarter 2017 Financial Results and Provides Business Update
12:00am